Genentech-partnered AC Immune tees up $68M IPO to bankroll Alzheimer’s R&D – FierceBiotech

September 14, 2016 by  
Filed under Alzheimers News

Sponsored By

FierceBiotech
Genentech-partnered AC Immune tees up $68M IPO to bankroll Alzheimer's R&D
FierceBiotech
AC Immune has set the terms for its long-mooted Nasdaq IPO. The Alzheimer's specialist, which lists Biogen ($BIIB), Genentech and Johnson & Johnson ($JNJ) among its partners, is looking to raise as much as $68 million (€61 million), the bulk of which
Swiss Alzheimer's biotech AC Immune eyes $700 million IPO valuationReuters

all 6 news articles »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*